How DXP uniquely solves the core challenges in this sector.
Guaranteeing document integrity for clinical trials
Isolating true drug efficacy from confounding variables
Securing cross-region R&D collaboration and meetings
Enforcing strict FDA/HIPAA compliance across all systems
Content Lake with Haephestus uses Merkle-tree validation and Git-based versioning for auditability.
fullSET applies Do-calculus and Granger causality to isolate accurate causal impacts.
WebRTC Collaboration Rooms offer encrypted, SIP-bridged communications with local AI transcription.
ARGUS manages unified identity and capability-based granular permissions across a 5-level scope hierarchy.
Core platform capabilities tailored for this industry.
Pharmaceuticals operate under the most intensive regulatory scrutiny of any industry. Drug discovery models screen billions of molecular candidates. Clinical trial analysis extracts adverse events from millions of patient records. Manufacturing quality control inspects every tablet, vial, and syringe with zero-tolerance for defects. And the FDA demands full data lineage for every AI-assisted decision — from training data to model version to inference output, with cryptographic integrity guarantees that Python-based inference engines cannot provide.
Prometheus delivers FDA-auditable AI inference. Active learning captures every human pharmacovigilance correction with full provenance — the model improves, and the regulators can prove it. Knowledge-grounded RAG links every drug interaction prediction to verified molecular databases with temporal validity — the model references governed pharmaceutical truth, not a hallucinated summary. Document intelligence extracts structured data from clinical study reports with per-field confidence scoring. causal audit audit trails satisfy 21 CFR Part 11 data integrity requirements. Every prediction, every model version, every data source — cryptographically verifiable from discovery through post-market surveillance.
Every batch record, every deviation, every signature — documented, traceable, and retrievable on demand.
XRP runs electronic batch manufacturing records, GMP compliance workflows, stability testing, serialization, and CAPA on one platform. Electronic signatures capture signer identity, intent, and record hash at every step. When a regulator asks for evidence, it is already assembled.
Active pharmaceutical ingredient tracking, supplier qualification with GMP audits, and certificate of analysis management. When an API lot is received, its chain of custody starts immediately — not at the first production use.
21 CFR Part 11, EU Annex 11, GMP, GxP, FDA, EMA, and country-specific drug regulations — pharma compliance is a moving target. XRP captures electronic signatures with signer identity, meaning, and record hash. Audit trails are built into every state change. When a regulator arrives, the evidence is already assembled.